A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders.
Sara AbdolahiAmeneh Zare-ChahokiFarshid NoorbakhshAli GorjiPublished in: Molecular neurobiology (2022)
Various neurotrophins (NTs), including nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, promote cellular differentiation, survival, and maintenance, as well as synaptic plasticity, in the peripheral and central nervous system. The function of microRNAs (miRNAs) and other small non-coding RNAs, as regulators of gene expression, is pivotal for the appropriate control of cell growth and differentiation. There are positive and negative loops between NTs and miRNAs, which exert modulatory effects on different signaling pathways. The interplay between NTs and miRNAs plays a crucial role in the regulation of several physiological and pathological brain procedures. Emerging evidence suggests the diagnostic and therapeutic roles of the interactions between NTs and miRNAs in several neuropsychological disorders, including epilepsy, multiple sclerosis, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, schizophrenia, anxiety disorders, depression, post-traumatic stress disorder, bipolar disorder, and drug abuse. Here, we review current data regarding the regulatory interactions between NTs and miRNAs in neuropsychological disorders, for which novel diagnostic and/or therapeutic strategies are emerging. Targeting NTs-miRNAs interactions for diagnostic or therapeutic approaches needs to be validated by future clinical studies.
Keyphrases
- bipolar disorder
- growth factor
- gene expression
- multiple sclerosis
- amyotrophic lateral sclerosis
- mild cognitive impairment
- major depressive disorder
- transcription factor
- signaling pathway
- white matter
- dna methylation
- depressive symptoms
- machine learning
- physical activity
- cancer therapy
- social support
- artificial intelligence
- cell proliferation
- functional connectivity